Pinto Marin, Alvaro alvaro.pinto@uam.es
Publications
- Articles 114
- Books 0
- Book chapters 2
- Conferences 4
- Working papers 1
- Technical reports 0
- Research projects 0
- Supervised theses 2
- Patent or software license 0
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.
- Pinto-Marín Á
- Trilla-Fuertes L
- Miranda Poma J
- Vasudev NS
- García-Fernández E
- López-Vacas R
- Miranda N
- Wilson M
- López-Camacho E
- Pertejo A
- Dittmann A
- Kunz L
- Brown J
- Pedroche-Just Y
- Zapater-Moros A
- de Velasco G
- Castellano D
- González-Peramato P
- Espinosa E
- Banks RE
- Fresno Vara JÁ
- Gámez-Pozo A
British Journal Of Cancer - 7/5/2025
- ISSN 00070920
- iMarina
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity
- Sibai M
- Cervilla S
- Grases D
- Musulen E
- Lazcano R
- Mo CK
- Davalos V
- Fortian A
- Bernat A
- Romeo M
- Tokheim C
- Barretina J
- Lazar AJ
- Ding L
- Grande E
- Alonso-Gordoa T
- Álvarez-Maestro M
- Andrada E
- Azueta A
- Javier Burgos RB
- Castellano D
- Climent MA
- Domínguez M
- Albert Font ID
- Galante I
- Galván P
- García JF
- García del Muro X
- Guerrero-Ramos F
- Malats N
- Marqués M
- Maroto P
- Martínez de Villarreal J
- Moreno-Oya A
- Paramio JM
- Pinto A
- Prat A
- Puente J
- Reig O
- Real FX
- Real FX
- Esteller M
- Bailey MH
- Porta-Pardo E
Cell Reports - 25/2/2025
10.1016/j.celrep.2024.115229 View at source
- ISSN 22111247
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
- Rodriguez-Vida A
- Valderrama BP
- Castellano D
- Pinto A
- Mellado B
- Puente J
- Climent MA
- Domenech M
- Vazquez F
- Perez-Gracia JL
- Bonfill T
- Morales-Barrera R
- Gonzalez-Billalabeitia E
- Garcia-del-Muro X
- Maroto P
- Navarro-Gorro N
- Juanpere N
- Juan O
- Bellmunt J
ESMO Open - 1/9/2024
10.1016/j.esmoop.2024.103690 View at source
- ISSN 20597029
Potential role of transmembrane 9 superfamily member 1 as a biomarker in urothelial cancer
- Pinto, Alvaro
- Ocanto, Abrahams
- Counago, Felipe
WORLD JOURNAL OF CLINICAL ONCOLOGY - 24/8/2024
10.5306/wjco.v15.i8.965 View at source
- ISSN 22184333
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)
- Fiala O
- Buti S
- Bamias A
- Massari F
- Pichler R
- Maruzzo M
- Grande E
- De Giorgi U
- Molina-Cerrillo J
- Seront E
- Calabrò F
- Myint ZW
- Facchini G
- Kopp RM
- Berardi R
- Kucharz J
- Vitale MG
- Pinto A
- Formisano L
- Büttner T
- Messina C
- Monteiro FSM
- Battelli N
- Kanesvaran R
- Büchler T
- Kopecký J
- Santini D
- Giudice GC
- Porta C
- Santoni M
Targeted Oncology (p. 587-599) - 1/7/2024
10.1007/s11523-024-01065-w View at source
- ISSN 17762596
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
- Massari F
- Santoni M
- Takeshita H
- Okada Y
- Tapia JC
- Basso U
- Maruzzo M
- Scagliarini S
- Büttner T
- Fornarini G
- Myint ZW
- Galli L
- Souza VC
- Pichler R
- De Giorgi U
- Gandur N
- Lam ET
- Gilbert D
- Popovic L
- Grande E
- Mammone G
- Berardi R
- Crabb SJ
- Kemp R
- Molina-Cerrillo J
- Freitas M
- Luz M
- Iacovelli R
- Calabrò F
- Tural D
- Atzori F
- Küronya Z
- Chiari R
- Campos S
- Caffo O
- Fay AP
- Kucharz J
- Zucali PA
- Rinck JA
- Zeppellini A
- Bastos DA
- Aurilio G
- Mota A
- Trindade K
- Ortega C
- Sade JP
- Rizzo M
- Fiala O
- Vau N
- Giannatempo P
- Barillas A
- Monteiro FSM
- Dauster B
- Mennitto A
- Nogueira L
- de Carvalho Fernandes R
- Seront E
- Aceituno LG
- Grillone F
- Cutuli HJ
- Fernandez M
- Bassanelli M
- Kopp RM
- Roviello G
- Abahssain H
- Procopio G
- Milella M
- Kopecky J
- Martignetti A
- Messina C
- Caitano M
- Inman E
- Kanesvaran R
- Herchhorn D
- Santini D
- Bamias A
- Bisonni R
- Mosca A
- Morelli F
- Maluf F
- Soares A
- Nunes F
- Pinto A
- Zgura A
- Incorvaia L
- Ansari J
- Zabalza IO
- Landmesser J
- Rizzo A
- Mollica V
- Marchetti A
- Rosellini M
- Sorgentoni G
- Battelli N
- Buti S
- Porta C
- Bellmunt J
CANCER IMMUNOLOGY IMMUNOTHERAPY - 1/6/2024
10.1007/s00262-024-03682-w View at source
- ISSN 03407004
Multidisciplinary consensus document on the current treatment of bacille Calmette-Guérin-unresponsive non-muscle invasive bladder tumor
- Guerrero-Ramos F
- Álvarez-Maestro M
- Pinto Marín
- Domínguez Escrig JL
- Rodríguez Faba
Actas Urologicas Espanolas (p. 262-272) - 1/5/2024
10.1016/j.acuro.2024.01.008 View at source
- ISSN 02104806
Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study
- García-Donas J
- de Velasco G
- Madurga R
- Chamorro J
- Rosero D
- Etxaniz O
- Pérez-Gracia JL
- Pinto Á
- Cacho D
- Barba M
- Borrega P
- Lázaro M
- Rodriguez L
- Villalobos L
- García L
- Cuellar A
- Solís-Hernández MP
- González A
- Pernaut C
- Rodríguez-Moreno JF
Clinical & Translational Oncology (p. 732-738) - 1/3/2024
10.1007/s12094-023-03295-2 View at source
- ISSN 1699048X
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
- Font A
- Mellado B
- Climent MA
- Virizuela JA
- Oudard S
- Puente J
- Castellano D
- González-del-Alba A
- Pinto A
- Morales-Barrera R
- Rodriguez-Vida A
- Fernandez PL
- Teixido C
- Jares P
- Aldecoa I
- Gibson N
- Solca F
- Mondal S
- Lorence RM
- Serra J
- Real FX
BRITISH JOURNAL OF CANCER (p. 434-441) - 24/2/2024
10.1038/s41416-023-02513-6 View at source
- ISSN 00070920
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors
- Pinto Marín, Alvaro
- Miranda, Jesús
- Pertejo Fernández, Ana
- Álvarez Maestro, Mario
- González Peramato, Pilar
- Aguilera Bazán, Alfredo
- García Fernández, MEugenia
- Trilla, Lucía
- Gámez Pozo, Angelo
- Espinosa Arranz, E
Clinical & Translational Oncology (p. 532-537) - 1/2/2024
10.1007/s12094-023-03274-7 View at source
- ISSN 1699048X
This researcher has no books.
Insuficiencia cardíaca, derrame pericárdico y síndrome de la vena cava superior
- Alvaro Pinto Marín
- Ana Sundlov
Tratado De Medicina Paliativa Y Tratamiento De Soporte Del Paciente Con Cáncer (p. 557-565) - 1/1/2007
- iMarina
Adherence to oral therapies in metastatic castration resistance (m CRPC) prostate cancer patients: The ADO PTA study.
- De la Llave, Sandra
- Carpeno, Laura
- Benedetti, Johanna
- Caries, Joan
- Puente, Javier
- Pinto, Alvaro
- Grande, Enrique
- Carballido, Joaquin
- Lorente, David
- Gonzalez-Billalabeitia, Enrique
- Morales, Rafael
- Gajate, Pablo
- Alfonso, Rosario
- Perez-Valderrama, Begona
- Gastaldo, Amparo Sanchez
- Fernandez, Fatima
- Calleja, Miguel Angel
- Duran, Ignacio
Journal Of Clinical Oncology (p. e18014-e18014) - 20/5/2017
10.1200/jco.2017.35.15_suppl.e18014 View at source
- ISSN 0732183X
Long-term functional results and quality of life after open partial laryngectomy and non-surgical larynx preservation.
- Castelo, Beatriz
- Castro, Alejandro
- Alberto Glaria, Luis
- Pinto, Alvaro
- del Palacio, Antonio
- Redondo, Andres
- Bernaldez, Ricardo
- Escribano, Ana
- Gavilan, Javier
- Espinosa, Enrique
Journal Of Clinical Oncology (p. e17056-e17056) - 20/5/2015
10.1200/jco.2015.33.15_suppl.e17056 View at source
- ISSN 0732183X
Safety of cabazitaxel (Cbz) in patients (pt) with metastatic transitional-cell carcinoma (mTCC) progressing to cisplatin-based chemotherapy: Results from the JEVTCC-SOGUG Study
- Duran, Ignacio
- Garcia del Muro, Xavier
- Vazquez-Estevez, Sergio
- Perez-Valderrama, Begona
- Angel Climent, Miguel
- Lainez, Nuria
- Sala, Nuria
- Isabel Saez, M.
- Maroto Rey, Jose Pablo
- Nogueron, Esther
- Font, Albert
- Gallardo Diaz, Enrique
- Pinto, Alvaro
- Jose Mendez-Vidal, Maria
- Lazaro Quintela, Martin
- Lopez Criado, M. Pilar
- Santander, Carmen
- Gonzalez del Alba, Aranzazu
- Luque, Raquel
- Angel Arranz, Jose;
Journal Of Clinical Oncology (p. e15537-e15537) - 1/1/2015
10.1200/jco.2015.33.15_suppl.e15537 View at source
- ISSN 0732183X
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer (MBC) treated with bevacizumab and weekly paclitaxel (Bev-Pac)
- Redondo, Andres
- Mendiola, Marta
- Martinez-Marin, Virginia
- Herranz, Jesus
- Yebenes, Laura
- Castelo, Beatriz
- Zamora, Pilar
- Pinto, Alvaro
- Cruz, Patricia
- Heredia, Victoria
- Diaz, Esther
- Gamez-Pozo, Angelo
- Angel Fresno-Vara, Juan
- Ramirez de Molina, Ana
- Hardisson, David
- Espinosa, Enrique;
Journal Of Clinical Oncology (p. 467-564) - 1/1/2014
10.1200/jco.2014.32.15_suppl.564 View at source
- ISSN 0732183X
This researcher has no technical reports.
This researcher has no research projects.
Validación de un modelo predictivo basado en la expresión de microRNA (BIO-MIR), para determinar el riesgo de recurrencia en pacientes con carcinoma renal de células claras en estadio temprano tratados con nefrectomía radical o parcial
- Gamez Pozo, Angelo (Director)
- Pinto Marín, Alvaro (Director) Doctorando: Jesús Miranda
1/1/2023
- iMarina
Perfiles géneticos con valor pronóstico en cáncer de mama localizado: Cómparación y validación mediante qrt-pcr a partir de muestras parafinadas
- Pinto Marín, Alvaro (Titulado/a)
- Zamora Auñon, Maria del Pilar (Autor o Coautor)
- Espinosa Arranz, Enrique (Autor o Coautor)
- Juan Ángel Fresno Vara (Director)
- Manuel Gonzalez Barón (Director)
- E (Director) Doctorando: Alvaro Pinto Marín
1/1/2009
- iMarina
This researcher has no patents or software licenses.
Researcher profiles
-
ORCID
-
Scopus Author ID
-
Dialnet id